The 5Ad Diet for Functional Bowel Disorders
Key facts
- Who runs it
- University of Suffolk
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 52 people enrolled
- Started
- 8 May 2022
- Ended
- 1 Apr 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- The 5Ad Diet
- The Low FODMAP Diet
- Record updated
- 24 November 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Individuals are eligible for the study if all of the following criteria are met:
- Suffers chronically from either constipation, diarrhoea, or an alternation of both, bloating, flatulence or abdominal pain, incomplete defecation, straining and bowel urgency
- Symptoms must be present for ≥ 2 times per week, with symptom onset occurring at least 3 months prior to participation
- Participants taking prescribed medications which may affect bowel function are included only if the intake is maintained throughout the entire intervention period
Who cannot take part
- History of abdominal/gastrointestinal surgery within 1 year prior to participation
- History of antibiotic use in the last 6 weeks prior to participation
- Known underlying pathology (e.g., Crohn's disease, ulcerative colitis, celiac disease)
- Allergic to the foods specified in both the 5Ad diet and the low FODMAP diet
- Individuals are excluded from the study if any of the following criteria are met:
- Pregnant
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this randomised controlled trial (RCT) is to compare the efficacy of the newly developed 5Ad diet against the widely researched low fermentable oligo-, di-, monosaccharide and polyols (FODMAP) diet in reducing gastrointestinal symptoms associated with functional bowel disorders/food intolerances.
Read full original descriptionShow less
The primary aims of this RCT are to determine:
* Whether the 5Ad diet is at least as effective as the low FODMAP diet in reducing gastrointestinal symptoms associated with FBDs/food intolerances. * Whether either the 5Ad diet or the low FODMAP diet are effective in reducing mental and physical fatigue.
To achieve the above aims, an RCT will be conducted with the 5Ad diet in one arm vs the active phase of the low FODMAP diet in the other arm, in a cross-over design with a 7 days washout phase in between. Both dietary protocols will be followed by each participant for 7 days.
Researchers will compare the results from the 2 dietary protocols in order to ascertain the superiority of one over the other in regards to 6 gastrointestinal symptoms (abdominal pain, bloating, flatulence, bowel urgency, straining and incomplete defecation), stool form and frequency of defecation.
The 2 groups in the trial
- The 5Ad DietExisting treatment, for comparison
Participants are required to follow the 5Ad diet for 7 days, followed by a washout phase for 7 days, before crossing over to the active phase of the low FODMAP diet for 7 days.
Treatment: The 5Ad Diet and The Low FODMAP Diet
- The Low FODMAP DietExisting treatment, for comparison
Participants are required to follow the active phase of the low FODMAP diet for 7 days, followed by a washout phase for 7 days, before crossing over to the 5Ad diet for 7 days.
Treatment: The 5Ad Diet and The Low FODMAP Diet
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The 5Ad Diet for Functional Bowel Disorders: A Randomised Controlled Trial Against the Low FODMAP Diet
- Record updated
- 24 November 2025